B2DG Events - 2008

Topic Speaker Title Company Datesort icon Location
Wicked questions for Digital Health David Kerr, MD Director of Research and Innovation Sansum Diabetes Center 12/31/2012 - 11:00pm Wilson
Holiday Break- No B2DG Meeting on Dec. 25 and Jan. 1. Next B2DG Mtg is an evening meeting on Jan 8th . . . 12/25/2012 - 8:30am Home with
Holiday Break- No B2DG Meeting on Dec. 18, 25 and Jan. 1. Next B2DG Mtg is an evening meeting on Jan 8th . . . 12/18/2012 - 8:30am Home with
Current Concepts in Treatment of the Diabetic Foot Ulcers and Other Chronic Wounds. Dr. Alex Reyzelman, MD Private Practice 12/11/2012 - 6:00pm Wilson
New skills wanted! Reinvent Your Life Science Profile to Stay in the Game Olivier Roth Marketing & Communication Coordinator Cliinovo 12/04/2012 - 8:30am Sunnyvale
How to avoid pitfalls in regulatory documentation and reduce risks during Inspections, Audits, and Litigation. Connie Hoy Vice President of Regulatory Affairs and Quality Assurance Cutera 11/27/2012 - 8:30am Sunnyvale
Thanksgiving Holiday Break . . 11/20/2012 - 8:30am With
Stellartech Success Story – A Medical Device Startup from Start to Finish Roger Stern, PhD President, CEO and Founder Stellartech 11/13/2012 - 6:00pm Wilson
Solving Start-Up Design Issues in Plastic Parts for Medical Products Howard R. Mullin Control Plastics 11/06/2012 - 8:30am Sunnyvale
Integrating Reimbursement into Early Stage Diagnostic Development Stanley Skrzypczak, M.S., M.B.A. Senior Director, Commercial Development Genomic Health 10/30/2012 - 8:30am Sunnyvale
Angel View on Investing Lee Rauch Founding Member HealthTech Capital 10/23/2012 - 8:30am Sunnyvale
An innovative way to deliver medical equipment and supplies to health systems in resource-poor regions of the world Chuck Haupt Executive Director MedShare, Western Region 10/16/2012 - 8:30am Sunnyvale
Biosimilar Pathway in U.S.: Regulatory and Legal Considerations Pauline Farmer-Koppenol Associate Fenwick and West 10/09/2012 - 6:00pm Fenwick
Bits, Bytes and Biology: A new paradigm for designing therapies. Pradeep Fernades President and co-founder Cellworks Group 10/02/2012 - 8:30am Sunnyvale
Global Regulatory Environment for Medical Devices Patrick Lee Regulatory Affairs Consultant Anson Group 09/25/2012 - 8:30am Sunnyvale
MEMS and Medical Applications Alissa M. Fitzgerald, Ph.D. Founder and Managing Member A. M. Fitzgerald & Associates, LLC 09/18/2012 - 8:30am Sunnyvale
Looking into the Medtech Crystal Ball: New Product Trends in Face of Challenges of Changing Environment Thomas J. Fogarty, MD Founder, Entrepreneur Fogarty Institute for Innovation 09/11/2012 - 6:00pm Fenick
No B2DG Meeting on September 4th - Enjoy the extended Holiday Break!! . . 09/04/2012 - 8:30am At Home
Creating Opportunities in the Life Sciences - Maintaining Self Employment in a Difficult Job Climate Daniel E. Levy, Ph.D Principal Consultant DEL BioPharma 08/28/2012 - 8:30am Sunnyvale
In the Trenches - The Jan Medical Story Part I Paul Lovoi, PhD Founder, CEO and President Jan Medical 08/21/2012 - 8:30am Sunnyvale
Orphan mitochondrial diseases as a translational segue to adult neurodegenerative disease Guy Miller, MD, PhD Chairman, CEO Edison Pharmaceuticals, Inc 08/14/2012 - 6:00pm Wilson
Butterfly effect in the pharmaceutical development Dr. Jayakumar Rajadas Founding Director of Biomaterials and Advanced Drug Delivery Laboratory Stanford University 08/07/2012 - 8:30am Sunnyvale
Biology and the Design of Surgical Laser Systems that work Doug Stinson, PhD New Product Realization Executive ' 07/31/2012 - 8:30am Sunnyvale
SBDX, What is it, How does it work, and Why was it not stopped--or Scanning Beam Digital X-ray technology for performing fluoroscopic X-ray imaging with minimum radiation Brian Wilfley, Ph.D. Director, Chief Scientist Triple Ring Technology 07/24/2012 - 8:30am Sunnyvale
Doc, What are my Chances? --Using Science and Nomograms to Improve the Diagnostic Process Joseph Marasco Software Executive . 07/17/2012 - 8:30am Sunnyvale
Development and Commercialization of Novel Universal Stem Cell Derived Therapeutic Ram Mandalam, Ph.D. President and CEO Cellerant Therapeutics Inc. 07/10/2012 - 6:00pm Wilson